1 / 36

Respiratory Disorders II

Respiratory Disorders II. Lecture Outline. 1- Spirometry: Volume/Time & Flow/Volume Curves . 2- Use of Spirometry in Obstructive & Restrictive Lung Diseases. 3- Spirometry Live Demonstration. 4- Aetiology & Pathological Features of Chronic Bronchitis.

harris
Télécharger la présentation

Respiratory Disorders II

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Respiratory Disorders II

  2. Lecture Outline 1- Spirometry: Volume/Time & Flow/Volume Curves 2- Use of Spirometry in Obstructive & Restrictive Lung Diseases 3- Spirometry Live Demonstration 4- Aetiology & Pathological Features of Chronic Bronchitis 5- Aetiology & Pathological Features of Emphysema 6- Effect of Obstructive Lung Disease on Lung Volumes & Capacities 7- Aetiology & Pathological Features of Restrictive Lung Disease 8- Respiratory Function Tests- Diagnostic Significance

  3. Spirometry Spirometry in the wards = 2 types - 1-Vol-time - 2- Flow- vol

  4. Spirometry- Vol/Time From fully inspired state patient expels all air in their lungs as forcefully as possible Normally, FEV1/FVC ratio= 0.8 or FEV1 = 80% FVC 6 5 4 75% Volume (L) Forced Vital Capacity FVC 3 FEV1 2 Slope of the initial line gives the flow rate FEF25% -75% 25% 1 0 0 1 2 3 4 Time (s)

  5. Forced Expiratory Flow (FEF 25% – 75% ) Measure of expiratory flow rate (V/t)over middle half of the FVC curve More conveniently done on Flow-Vol spirometry … Directly read off from the curve SIG = Early airflow obstruction

  6. Vol-Time Spirometry in Obstructive Lung Disease 6 5 Obstructive Lung Disease Total Volume (TLC and FVC) may be normal but FEV1 is reduced And FEV1/FVC ratio <0.8 (<50% here) 4 Volume (L) 3 Forced Vital Capacity 2 FEV1 1 0 0 1 2 3 4 Time (s)

  7. Vol-Time Spirometry in Restrictive Lung Disease 6 Restrictive Lung Disease: Total Volume reduced and FVC reduced, FEV1 reduced But FEV1/FVC ratio = NORMAL! 5 4 Volume (L) Forced Vital Capacity 3 2 FEV1 1 0 0 1 2 3 4 Time (s)

  8. Spirometry: Flow/Volume Loop Measurement of flow rates; contemporary technique PEF FEF 25 6 ● 1 sec 4 FEF75 1 s mark Expiration ● 2 Expired Lung Volume (L) Flow (L s-1) 0 1 2 3 4 5 2 Inspiration Vital Capacity 4 6

  9. Spirometry: Demonstration

  10. Flow/Volume Loops inObstructive Lung Disease 6 PEF 4 FEF50 ● 1 sec Expiration 2 ● Flow (L s-1) 0 Lung Volume (L) 1 2 3 4 5 2 Inspiration 4 Scooped out appearance FIF50 6

  11. Flow/Volume Loops inRestrictive Lung Disease 6 PEF FEF50 4 ● 1 sec Expiration 2 ● Flow (L s-1) 0 Lung Volume (L) 1 2 3 4 5 2 Inspiration 4 FIF50 6

  12. Chronic Obstructive Lung Diseases (COPDs) Chronic Bronchitis Clinical definition: “A cough productive of sputum on most days for three months of the year, for at least two consecutive years”- WHO- CD10 • Airways show Hypersecretion of mucus with mucus gland Hyperplasia = an increase in airflow resistance in the large airways • The airway obstruction is due to Luminal Narrowing and MucusPlugging Could be part of underlying disease process; eg asthma, cystic fibrosis, Dyskinetic cilia syndrome…etc – Not 1ry diagnosis

  13. Chronic Bronchitis Hypertrophy of submucosal glands & Hyperpalsia of goblet cells Metaplasia: Ciliated Columnar Ep cells Replaced by Squamous Ep cells

  14. Chronic Bronchitis Chronic Bronchitis leads to: 1. Alveolar Hypoventilation 2. Hypoxaemia (low arterial PO2) 3. Hypercapnia (↑blood CO2) 4. Respiratory Failure may occur • Individuals are typically cyanosed but may not have Dyspnoea (Respiratory distress) • In some cases chronic bronchitis may lead to Hypoxic Pulmonary Vasoconstriction, and Secondary Pulmonary Hypertension • This may lead to right sided heart failure

  15. Emphysema • Permanent enlargement (dilation) of any part respiratory acinus (distal to the bronchi) • Destruction of alveolar walls (without scarring) • Loss of elastic recoil in the lungs as the respiratory tissue is destroyed • Thus: area for gas exchange is reduced • There are two patterns: 1. CENTRIACINAR 2. PANACINAR Acinus = Terminal duct + alveoli

  16. The Acinus in Emphysema

  17. Emphysema Acinus in Emphysema

  18. Emphysema Air trapping, Increased RV Increased FRC, TLC

  19. Emphysema • Proposed to be caused by unregulated activity of extracellular proteases secreted from inflammatory cells • This is a response to chronic exposure to cigarette smoke or other inhaled irritants • Linked to an imbalance of proteaseand the protease inhibitor 1-antitrypsin • Proteases (particularly Elastase) cause the breakdownof alveolar walls and collapse of small airways

  20. Antielastase activity Smoking Elastic Damage Elastase Emphysema Aetiology of Emphysema 1 Antitrypsin Deficiency (genetic)

  21. Emphysema • The classic presentation = barrel-chested and dyspnoeic • Patients have prolonged expiration and may sit forward in a hunched position attempting to squeeze the air out of the lungs • The loss of elastic recoil and structural support leads to: 1. Trapping of air in lungs 2. Over inflated lungs 3. Decreased rate of airflow on expiration

  22. Emphysema • Reduced oxygen uptake despite increased ventilation • blood oxygenation may be maintained by rapid respiration, but subjects breathless on the slightest exertion and become hypoxic • Patients are known as ‘PINK PUFFERS’ • Cyanosis, hypercapnia and cor pulmonale (enlargement of the right ventricle) occur late in the disease after progressive decline in lung function

  23. Emphysema • Emphysema progresses slowly and worsens over time. • Increased effort in breathing leads to progressive breathlessness • Some do not progress (Pink Puffers) • In some cases the disease progresses leading to chronic hypoxia and hypercapnia (Blue Bloaters)

  24. Effects of Obstructive Disease on Lung Volumes • • TLC is elevated (why?) • • Residual Volume is elevated • • Expiratory Capacity is elevated • So FRC is elevated (What about IRV & IC?) • Elevations are due to air trapped in lungs • following expiration • • Vital capacity may be reduced • • FEV1 is reduced

  25. Effects of Obstructive Disease on Lung Volumes • Airflow is reduced due to airway obstruction. • VC and FEV1 are reduced but  FEV1 is >  FVC Therefore FEV1/FVC ratio is much lower than the normal 70% - 80% of FVC (as low as 25%)

  26. Restrictive Lung Diseases • Restrictive lung diseases are caused by a reduction in total lung capacity • Features include: 1. Increased Lung Density (Stiff Lung). 3. Reduced Compliance (V/P) 4. Breathlessness (Dyspnoea) 5. Greater Effort to Inflate Lungs 6. Abnormality of Alveolar Walls which renders them rigid

  27. Restrictive Lung Diseases • Characterised by damage to the alveolar walls and capillaries • An increase in interstitial fluid or fibrosis produce a stiff lung • Damage to the alveolar epithelium and vasculature produce abnormalities in the ventilation/ perfusion ratio (normally 5/6 ~ 0.8)

  28. Restrictive Lung Disease • ACUTE - Adult Respiratory Distress Syndrome (ARDS) Trauma or acute illness Inflammation of lung paranchyma- pulmonary edema- eg Pneumonia • CHRONIC - Pneumoconiosis- occupational lung disease- Asbestosis silicosis, byssinosis (cotton dust) - Idiopathic Pulmonary Fibrosis (IPF)-unknown cause - Sarcoidosis- immune system disorder- small inflammatory nodules (granulomas)- leading to fibrosis

  29. Chronic Restrictive Lung Diseases • Develop over months/years and leads to a slowly decreasing respiratory efficiency • With chronic interstitial fibrosis leading to ‘honeycomb’ lung • There is an infiltration of macrophages and microcyst formation. • Clinically patients exhibit dyspnoea, cough and in advanced caseshypoxemia and cyanosis, eventually respiratory failure

  30. Honeycomb lung

  31. Proposed Mechanism for Fibrosis Unknown Antigen T Lymphocyte B Lymphocyte Activated Macrophage cytokines Immune complexes Fibrogenic cytokines Fibrogenic cytokines Fibroblasts Oxidants & Proteases Injury to type I pneumocytes (epithelial cells)

  32. Macrophage in alveolus

  33. Effects of Restrictive Disease on Lung Volumes • • Reduced FVC • • Reduced FEV1 • • Relatively Normal FEV1/FVC ratio • • Relatively Normal PEFR • • TLC is reduced (Why?) • Inspiratory capacity is reduced. • • Residual Volume is normal • Reflect loss of compliance

  34. Respiratory Function Tests – Diagnostic Significance • Peak Expiratory Flow Rate - Reduced with obstructive lung disease. • FEV1- * Reduced with obstructive disease * Reduced with pulmonary fibrosis (restrictive) • Forced Vital Capacity (FVC) - * Reduced in COPD * Reduced with a corresponding decrease in total lung volume in fibrosis or oedema * Reduced with muscle weakness

  35. Respiratory Function Tests – Diagnostic Significance Forced Expiratory Ratio: FEV1/FVC - * Low in obstructive lung disease * Normal or high in restrictive defects

  36. Thanks & Good Luck!

More Related